sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Europe Rnai Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00015148
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 136
Buy Now

Europe RNAi Therapeutics Market Scope and Key Players Analysis by 2027

Buy Now

Europe RNAi Therapeutics Market Report Europe RNAi Therapeutics Market Size and Share Europe RNAi Therapeutics Market Scope and Analysis

Europe RNAi Therapeutics Market Report Scope

Report Attribute Details
Market size in 2019 US$ 170.42 Million
Market Size by 2027 US$ 324.33 Million
Global CAGR (2020 - 2027) 8.4%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Molecule Type
  • Small Interfering RNAs
  • MicroRNA
By Application
  • Genetic Disorders
  • Oncology
  • Neurodegenerative Disorders
  • Cardiovascular
  • Respiratory Disorders
  • Infectious Diseases
  • Renal Diseases
By Route of Administration
  • Intradermal Injections
  • Pulmonary Delivery
  • Intravenous Injections
  • Intraperitoneal Injections
By End User
  • Diagnostic Laboratories
  • Research and Academic Laboratories
  • Hospitals
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Sanofi
  • GlaxoSmithKline plc
  • Silence Therapeutics
  • Alnylam Pharmaceuticals Inc
  • Arrowhead Pharmaceuticals Inc
    		•